Historia de la parasitología chilena

278 Revista Parasitología Latinoamericana - Historia de la Parasitología Chilena Capítulo 14 Proyectos Fondecyt Regular Quantitative parasitemia and genotyping of trypanosoma cruzi strains as evaluation strategies of evaluacion efficacy in chronic chagas disease treatment. IP: Inés Zulantay Co-I: Werner Apt Genotypes and parasitological load as risk factors in the development of cardiopathy inpatientswithchagasdisease. IP:Werner Apt Co-I: InésZulantay The persistent negativization of parasitemia in prolonged follow-up is a biomarker predictive of cure in the treatment of chronic chagas disease. End- point study, nine years after intervention with nifurtimox. IP: Inés Zulantay Co-I: Werner Apt Proyectos Internacionales EULACHealth-FONDEF-FONIS Towards personalized treatment of chagas disease by molecular profiling of parents and parasites. IP: Lorenzo Bermejo (Alemania), IP Chile: Werner Apt, Coordinador Chile: Inés Zulantay Phase ii clinical trial withposaconazole. Treatment of chronic chagas disease. Multinational study. IP Chile: Werner Apt, Coordinador Chile: Inés Zulantay Producto de estos proyectos, se han generado numerosas publicaciones nacionales e internacionales en diversas revistas de la especialidad. Mencionaremos algunas de ellas: . Apt,W.;Carrasco,D.;Fuentealba,C.;Canals,M.;Muñoz,G.;Saavedra,M.;Castillo, JP.;Zulantay, I.ChronicChagasdisease:Quantificationof Trypanosomacruzi inperipheral bloodanddejectionsof Triatoma infestans fedbyxenodiagnosis in patients with and without cardiopathy. Acta Trop. 2019, 200, 105167. . Apt, W.; Llancaqueo M.; Zulantay, I.; Canals, M.; Kara, S.; Arribada, A.; Muñoz, G.;Martínez, G. Clinical, electrocardiographicandechocardiographic evolution of chronic Chagas disease treatedwith nifurtimox on prolonged follow-up inChile: observational study. JGlobAntimicrobResist. 2021, 27,160. . Apt, W.; Zulantay, I.; Salas P. Treatment of Chagas disease. New schemes. Rev Med Chil . 2022, 150,1689.